Objectives: In fulminant type 1 diabetes mellitus (fT1DM), plasma glucose (PG) levels are strongly increased, unlike glycated hemoglobin (HbA) levels, resulting in a sharply increased PG/HbA ratio. We investigated the PG/HbA ratio in fT1DM and tested the accuracy of cutoff points to easily and efficiently differentiate fT1DM from diabetic ketoacidosis (DKA).
Methods: We report 41 cases of fT1DM in which PG/HbA ratio was studied as a novel clinical parameter to predict fT1DM. Clinical and biochemical characteristics were analyzed in 41 fT1DM and 51 DKA patients in China. Receiver-operating characteristic curve analysis was used to identify PG/HbA ratio cutoff points to differentiate fT1DM from DKA.
Results: PG/HbA ratio was significantly higher in fT1DM patients (7.24±2.49mmol/L/%; i.e., 0.88±0.36L/mol) than in DKA patients (2.60±0.69mmol/L/%; i.e., 0.06±0.01L/mol) (P<0.001). PG/HbA ratio exceeded 4.2mmol/L/% (i.e., 0.6 l/mol) in 39 of the 41 fT1DM patients (95.1%), versus only 1 of the 51 DKA patients (1.9%).
Conclusions: PG/HbA ratio is a simple tool that may be useful to identify DKA patients at high risk of fT1DM. PG/HbA ratio with a threshold of≥4.2mmol/L/% (i.e., 0.6L/mol) can be adopted as a new clinical parameter in predicting fT1DM.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ando.2018.01.006 | DOI Listing |
Diabetologia
January 2025
MRC Epidemiology Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
Aims/hypothesis: UK standard care for type 2 diabetes is structured diabetes education, with no effects on HbA, small, short-term effects on weight and low uptake. We evaluated whether remotely delivered tailored diabetes education combined with commercial behavioural weight management is cost-effective compared with current standard care in helping people with type 2 diabetes to lower their blood glucose, lose weight, achieve remission and improve cardiovascular risk factors.
Methods: We conducted a pragmatic, randomised, parallel two-group trial.
Endocr Pract
January 2025
Department of Nephrology, Shanghai Tenth People's Hospital, Shanghai, China. Electronic address:
Objectives: Fasting plasma glucose (FPG), glycated hemoglobin A (HbA), and 2-hour post-load plasma glucose (2h PG) are all currently used to define prediabetes. We aimed to determine whether a higher number of prediabetes defects corresponds to an increased all-cause and cardiovascular disease (CVD) mortality.
Methods: Individuals with prediabetes and available information on FPG, HbA, 2h PG, and mortality data were derived from the 2005 - 2016 National Health and Nutrition Examination Survey.
Ann Intern Med
September 2024
Departments of Pediatrics and Medicine, Case Western Reserve University, and University Hospitals Cleveland Medical Center, Cleveland, Ohio (G.A.M.).
Diabetes Res Clin Pract
June 2024
Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong Special Administrative Region. Electronic address:
Background: We compared performance of high 1-hour PG level, impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) in predicting type 2 diabetes in a longitudinal community-based cohort of Hong Kong Chinese.
Methods: Between 2001 and 2003, 472 adults aged 18-55 years without diabetes underwent 75-gram oral glucose tolerance test (OGTT). Between 2012 and 2014, progression to diabetes was ascertained by reviewing medical records or repeating OGTT and HbA.
Int J Mol Sci
March 2024
Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan.
The delineation of biomarkers and neuropsychiatric symptoms across normal cognition, mild cognitive impairment (MCI), and dementia stages holds significant promise for early diagnosis and intervention strategies. This research investigates the association of neuropsychiatric symptoms, evaluated via the Neuropsychiatric Inventory (NPI), with cerebrospinal fluid (CSF) biomarkers (Amyloid-β42, P-tau, T-tau) across a spectrum of cognitive states to enhance diagnostic accuracy and treatment approaches. Drawing from the National Alzheimer's Coordinating Center's Uniform Data Set Version 3, comprising 977 individuals with normal cognition, 270 with MCI, and 649 with dementia.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!